Marchetti C - Search Results

1

Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.

Marchetti C, Toldo S, Chojnacki J, Mezzaroma E, Liu K, Salloum FN, Nordio A, Carbone S, Mauro AG, Das A, Zalavadia AA, Halquist MS, Federici M, Van Tassell BW, Zhang S, Abbate A. Marchetti C, et al. J Cardiovasc Pharmacol. 2015 Jul;66(1):1-8. doi: 10.1097/FJC.0000000000000247. J Cardiovasc Pharmacol. 2015. PMID: 25915511 Free PMC article.

2

Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse.

Toldo S, Mezzaroma E, Van Tassell BW, Farkas D, Marchetti C, Voelkel NF, Abbate A. Toldo S, et al. Among authors: marchetti c. Exp Physiol. 2013 Mar;98(3):734-45. doi: 10.1113/expphysiol.2012.069831. Epub 2012 Nov 23. Exp Physiol. 2013. PMID: 23180808 Free PMC article.

3

A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse.

Marchetti C, Chojnacki J, Toldo S, Mezzaroma E, Tranchida N, Rose SW, Federici M, Van Tassell BW, Zhang S, Abbate A. Marchetti C, et al. J Cardiovasc Pharmacol. 2014 Apr;63(4):316-322. doi: 10.1097/FJC.0000000000000053. J Cardiovasc Pharmacol. 2014. PMID: 24336017 Free PMC article.

4

Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice.

Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D, Samidurai A, Van Tassell BW, Yin C, Ockaili RA, Vigneshwar N, Mukhopadhyay ND, Kukreja RC, Abbate A, Salloum FN. Toldo S, et al. Among authors: marchetti c. Circ Cardiovasc Genet. 2014 Jun;7(3):311-20. doi: 10.1161/CIRCGENETICS.113.000381. Epub 2014 May 13. Circ Cardiovasc Genet. 2014. PMID: 24825878 Free PMC article.

5

Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse.

Toldo S, Mezzaroma E, Bressi E, Marchetti C, Carbone S, Sonnino C, Van Tassell BW, Abbate A. Toldo S, et al. Among authors: marchetti c. J Cardiovasc Pharmacol. 2014 Jul;64(1):1-6. doi: 10.1097/FJC.0000000000000106. J Cardiovasc Pharmacol. 2014. PMID: 25006675

6

Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.

Toldo S, Mezzaroma E, McGeough MD, Peña CA, Marchetti C, Sonnino C, Van Tassell BW, Salloum FN, Voelkel NF, Hoffman HM, Abbate A. Toldo S, et al. Among authors: marchetti c. Cardiovasc Res. 2015 Feb 1;105(2):203-12. doi: 10.1093/cvr/cvu259. Epub 2014 Dec 18. Cardiovasc Res. 2015. PMID: 25524927 Free PMC article.

7

Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.

Toldo S, Marchetti C, Mauro AG, Chojnacki J, Mezzaroma E, Carbone S, Zhang S, Van Tassell B, Salloum FN, Abbate A. Toldo S, et al. Among authors: marchetti c. Int J Cardiol. 2016 Apr 15;209:215-20. doi: 10.1016/j.ijcard.2016.02.043. Epub 2016 Feb 4. Int J Cardiol. 2016. PMID: 26896627

8

Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition.

Toldo S, Mauro AG, Marchetti C, Rose SW, Mezzaroma E, Van Tassell BW, Kim S, Dinarello CA, Abbate A. Toldo S, et al. Among authors: marchetti c. J Cardiovasc Pharmacol. 2016 Jul;68(1):27-32. doi: 10.1097/FJC.0000000000000383. J Cardiovasc Pharmacol. 2016. PMID: 26945157

9

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.

Valle Raleigh J, Mauro AG, Devarakonda T, Marchetti C, He J, Kim E, Filippone S, Das A, Toldo S, Abbate A, Salloum FN. Valle Raleigh J, et al. Among authors: marchetti c. Cardiovasc Res. 2017 May 1;113(6):609-619. doi: 10.1093/cvr/cvw246. Cardiovasc Res. 2017. PMID: 28073832

10

A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.

Mauro AG, Mezzaroma E, Marchetti C, Narayan P, Del Buono MG, Capuano M, Prestamburgo A, Catapano S, Salloum FN, Abbate A, Toldo S. Mauro AG, et al. Among authors: marchetti c. J Cardiovasc Pharmacol. 2017 May;69(5):273-278. doi: 10.1097/FJC.0000000000000474. J Cardiovasc Pharmacol. 2017. PMID: 28195949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters